UK-South Korea Digital Health CRD
£3m available for UK registered SMEs and eligible South Korean partners for business led Digital Health R&D projects with academic collaboration.
Innovate UK and the Medical Research Council (MRC), part of UK Research and Innovation, will work with the Korea Health Industry Development Institute (KHIDI) to invest up to £3 million in innovation projects.
The aim of this competition is to fund business led, collaborative research and development (CR&D) projects. Projects must aim to deliver economic, knowledge and health benefit through industrial innovation and academic collaboration in the area of Digital Health for the UK and South Korea.
Consortia must be led by a UK SME, include a UK registered academic or research & technology organisation, and include at least two eligible organisations registered in South Korea that are separate non-linked entities.
South Korean partners must apply to and will be funded by KHIDI for the South Korean component of the project set out in this application. The project must be independently selected by both Innovate UK and KHIDI to be awarded funding.
To lead a project your organisation must:
- be a grant claiming UK registered micro, small or medium-sized enterprise (SME)
- collaborate with a UK registered academic or research and technology organisation (RTO)
- collaborate with at least two eligible South Korean registered organisations, which must be separate non-linked entities to the UK project partners
To collaborate with the lead, your organisation must be one of the following UK registered:
- micro, small or medium-sized enterprise (SME)
- academic institution
- research and technology organisation (RTO)
A UK SME can only lead on one application. If leading one application, a UK SME can be included as a collaborator in one further application.
A UK SME that is not leading an application can collaborate on up to 2 applications.
A UK registered academic institution or RTO can collaborate on any number of applications.
Subcontractors are allowed in this competition and are limited to no more than 20% of the total eligible costs of the UK participation.
Your project must:
- have a maximum grant funding request of no more than £750,000
- start by 1st November 2023
- end by 30 April 2026
- last between 24 and 30 months
UK project partners must carry out the majority of their project work in the UK and intend to exploit the results from or in the UK.
Your project must demonstrate:
- a clear game changing or disruptive innovative idea linked to knowledge generation which contributes towards our understanding of human health conditions and leading to new products, processes or services
- improvement to the prevention, diagnosis, prognosis or treatment of significant health needs
- meaningful collaboration and transfer of knowledge between academic, RTO and business project partners
- a clear, evidence based business case that addresses and documents market potential and needs and that sets out the return on investment
- a strong and deliverable business that includes sound, practical financial plans and timelines
- good value for money which will always be a consideration in Innovate UK and MRC funding decisions
- clear potential to benefit the UK economy or national productivity
- the benefits to participants from the countries working together
- a clear definition of where intellectual property (IP) can be used and shared between the participants and countries
- a clear route to market within 2 to 3 years of project completion
Your project must focus on digital health. This may include digital tools, technologies, and solutions to improve health. These technologies include a wide range of devices, software, and platforms that leverage digital and mobile technologies.
Examples of areas of focus include:
- developing tools for improving analysis of medical imaging or data for clinical diagnosis, risk identification, patient stratification and disease monitoring
- data platforms for better integration of electronic health records, including opportunities for the use of data for further research
- tools to support point-of-care diagnosis and surveillance modelling
- digital tools to support management of diseases and delivery of psychological therapies
This list is not meant to be exhaustive.